80 results
8-K
EX-10.1
BNTC
Benitec Biopharma Inc
18 Apr 24
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million
9:45pm
for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee … directors established for such purpose for services rendered to the Company, (b) securities upon the exercise or exchange of or conversion of any Securities
8-K
EX-10.3
BNTC
Benitec Biopharma Inc
18 Apr 24
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million
9:45pm
for such purpose. The use of a single agreement with respect to the obligations of the Company contained was solely in the control of the Company, not the action
8-K
EX-10.4
BNTC
Benitec Biopharma Inc
18 Apr 24
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million
9:45pm
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as a so-called “director by deputization”, for the purpose of exempting, to the extent
8-K
EX-10.2
BNTC
Benitec Biopharma Inc
18 Apr 24
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million
9:45pm
purpose and effect as such Rule.
“Rule 424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended … or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
8-K
EX-4.1
BNTC
Benitec Biopharma Inc
18 Apr 24
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million
9:45pm
for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders … , upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time
S-8
y4urv5goistn5p
22 Dec 23
Registration of securities for employees
8:02pm
S-8
cm0f48ypy9ig6
22 Dec 23
Registration of securities for employees
8:02pm
8-K
EX-1.1
wkb8g6l b5f
11 Aug 23
Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering
4:01pm
8-K
EX-4.3
9q42iuaoptgwntnw7
11 Aug 23
Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering
4:01pm
8-K
EX-4.2
p5dur7m 8m6
11 Aug 23
Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering
4:01pm
8-K
EX-4.1
oiqu1c vd
11 Aug 23
Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering
4:01pm
424B4
zkqn5 syvvcd
10 Aug 23
Prospectus supplement with pricing info
4:06pm